ABT card
ABT price forecast
Abbott Laboratories$107,45
P/E now is 39,9. Average over 5 years: 28,2 (range 23–35). The stock is 42% above its history.
Base · FY2030
$174,62+14,8% a year
The base case gives 14,8% a year, above your target of 10%.
Settings
%
No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.
Calculated from your assumptions. Not an investment recommendation.
Base · FY2030$174,62+14,8% a year